Effects of deleted in liver cancer 1 gene transfection on the proliferation and migration of human ovarian cancer cell line OVCAR-3
Huina Liu
Abstract
Huina Liu
Abstract
Objective:To investigate the effects of deleted in liver cancer 1(DLC1) gene on the proliferation and migration of human ovarian cancer cell line OVCAR-3.Methods:The recombinant plasmid pEGFP-C3-DLC1 was transfected into OVCAR-3 cells by lipofectAMINE.The expressions of DLC1 mRNA and protein before and after transfection were detected by reverse transcriptase-polymerase chain reaction(RT-PCR) and Western blotting,respectively.The proliferation,cell cycle and migration ability of OVCAR-3 cells were determined by methyl thiazolyl tetrazolium(MTT) assay,flow cytometry and Transwell chamber assays in vitro,respectively.The protein expressions of focal adhesion kinase(FAK),c-Jun NH2-terminalprotein kinase(JNK),phospho-FAK(p-FAK)-Y925 and phospho-JNK(p-JNK)-Thr183/Tyr185 were detected by Western blotting.Results:Stable expressions of DLC1 mRNA and protein were observed in OVCAR-3 cells after transfection with DLC1 gene.The proliferation and migration abilities of OVCAR-3 cells were significantly reduced after transfection with DLC1 gene,and the cell cycle was arrested at G0/G1 phase(P0.01).The protein expressions of p-FAK(Y925) and p-JNK(Thr183/Tyr185) were markedly decreased in OVCAR-3 cells after transfection with DLC1 gene(P0.01).Conclusion:DLC1 gene can inhibit the proliferation and migration abilities of ovarian cancer cells through down-regulation of p-FAK(Y925) and p-JNK(Thr183/Tyr185) proteins,which leads to G0/G1 cell cycle arrest.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the effects of deleted in liver cancer 1(DLC1) gene on the proliferation and migration of human ovarian cancer cell line OVCAR-3.Methods:The recombinant plasmid pEGFP-C3-DLC1 was transfected into OVCAR-3 cells by lipofectAMINE.The expressions of DLC1 mRNA and protein before and after transfection were detected by reverse transcriptase-polymerase chain reaction(RT-PCR) and Western blotting,respectively.The proliferation,cell cycle and migration ability of OVCAR-3 cells were determined by methyl thiazolyl tetrazolium(MTT) assay,flow cytometry and Transwell chamber assays in vitro,respectively.The protein expressions of focal adhesion kinase(FAK),c-Jun NH2-terminalprotein kinase(JNK),phospho-FAK(p-FAK)-Y925 and phospho-JNK(p-JNK)-Thr183/Tyr185 were detected by Western blotting.Results:Stable expressions of DLC1 mRNA and protein were observed in OVCAR-3 cells after transfection with DLC1 gene.The proliferation and migration abilities of OVCAR-3 cells were significantly reduced after transfection with DLC1 gene,and the cell cycle was arrested at G0/G1 phase(P0.01).The protein expressions of p-FAK(Y925) and p-JNK(Thr183/Tyr185) were markedly decreased in OVCAR-3 cells after transfection with DLC1 gene(P0.01).Conclusion:DLC1 gene can inhibit the proliferation and migration abilities of ovarian cancer cells through down-regulation of p-FAK(Y925) and p-JNK(Thr183/Tyr185) proteins,which leads to G0/G1 cell cycle arrest.
Key concepts: Transfection, Cell cycle, Cell growth, Molecular biology, Biology, Lipofectamine, Focal adhesion, Blot